Complimentary & Alternative Medicine

>

Latest News

FDA Clears Phase 2 Study of Cannabis for PTSD Treatment in Veterans / Image credit: ©Soru Epotok/AdobeStock
FDA Clears Phase 2 Study of Cannabis for PTSD Treatment in Veterans

November 21st 2024

After a 3-year negotiation, the FDA has cleared a phase 2 clinical trial assessing the use of smoked cannabis for the treatment of PTSD symptoms in veterans.

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: Medicinal Cannabis for Cancer-related Pain

May 8th 2023

Melatonin Gummies May Have a Higher Dose than Indicated on Label, Putting Children at Risk
Melatonin Gummies May Have a Higher Dose than Indicated on Label, Putting Children at Risk

April 27th 2023

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: Cannabis Use & Coronary Artery Disease

February 27th 2023

Frequent Cannabis Use Associated with Higher Risk of Coronary Artery Disease
Frequent Cannabis Use Associated with Higher Risk of Coronary Artery Disease

February 24th 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.